Lamotrigine [6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine], is a broad-spectrum antiepileptic, used as monotherapy and as an adjunct with other antiepileptics for treatment of partial and generalized tonic-clonic seizures. Its use to treat neurological lesions and as a tranquilizer also has been studied.
1,2)
Lamotrigine is not official in any pharmacopoeia, two stability indicating HPLC methods with UV detection at 210 nm have been reported with either longer analysis time 3) or at definite temperature 40°C. 4) The present HPLC method differs from those reported previously 3, 4) in terms of mobile phase, pH and temperature, so the main advantage is that the analysis was proceeded at ambient temperature (25Ϯ5°C) not at definite temperature 40°C. Moreover, an UV spectrophotometric method using 0.1 M sodium hydroxide was reported for its determination in tablets. 5) But no work seems to have been done on colorimetric assay.
Most methods for lamotrigine analysis utilized HPLC technique in biological fluids. [6] [7] [8] [9] [10] [11] [12] Few methods have been published for its determination including thin layer chromatography which needs 2 h for tank saturation and can not determine lamotrigine in presence of its impurity, 5) gas chromatography, 13) capillary electrophoresis 14, 15) and immunoassay. 16, 17) In the present study we suggest a simple selective and validated spectrophotometric method using p-chloranilic acid which is used as chromogenic agent for different drugs, it gives an immediate purple chromogen at room temperature. 18 ) Also TLC and HPLC methods that can identify and quantitate lamotrigine in presence of its impurity 2,3-dichlorobenzoic acid, in bulk and dosage form.
All solutions were kept in a refrigerator at 4°C and were stable for one week.
Synthetic Mixtures Aliquots of standard solutions of 2,3-dichlorobenzoic acid equivalent to 0.1-10% were added to the standard solutions of lamotrigine containing 2 mg (for spectrophotometric and TLC method) and 0.08 mg (for HPLC method), and the volumes were completed with the appropriate solvents to 10 ml for sspectrophotometric, HPLC methods and to 5 ml for TLC.
Sample Preparation Ten tablets were accurately weighed and finely powdered. An amount equivalent to 100 mg lamotrigine was transferred into 100 ml volumetric flask, and dissolved in 50 ml acetone or methanol. The solution was stirred with magnetic stirrer for 10 min, filtered and the volume was completed to the mark.
Chromatographic Conditions For TLC method, the plates were developed in ethyl acetate : methanol : ammonia 35% (17 : 2 : 1 v/v/v) as the mobile phase. For detection and quantification, 10 ml each of the sample solutions and standard solutions of different concentrations within the linearity range were applied as separate compact spots 10 mm apart and 15 mm from the bottom of the TLC plate using 25 ml Hamilton microsyringe. The chromatographic tank was saturated with the mobile phase for 30 min before development of the plates. The plates were developed up to 8 cm in the usual ascending way, air-dried, and scanned for lamotrigine at 275 nm by using the instrumental parameters mentioned above.
For HPLC method, the mobile phase was prepared by mixing acetonitrile : methanol : 0.01 M potassium orthophosphate adjusted with phosphoric acid to pH 6.7Ϯ0.1, in the proportions of (30 : 20 : 50 v/v/v). It was filtered by using a 0.45 mm membrane filter and degassed in an ultrasonic bath before use. The samples were also filtered by using 0.45 mm Teflon filters. The flow rate was set at 1.5 ml/min and UV detector at 275 nm. The column was conditioned for Ն30 min. All determinations were performed at ambient temperature 25Ϯ5°C and the injection volume was 20 ml.
Procedures. Calibration for Spectrophotometric Method Aliquots of standard solution (1 mg ml Ϫ1 ) equivalent to (0.1-2 mg) lamotrigine were transferred into 10 ml volumetric flasks. p-Chloranilic acid solution (3 ml) was added and the volume was completed to the mark with acetone. Absorbance of the colored product was measured at l max 519 nm. The calibration curve was plotted and the regression equation was recorded.
Calibration for TLC Method Aliquots of standard solution (1 mg ml Ϫ1 ) equivalent to (0.25-5 mg) lamotrigine were transferred into a series of 5-ml volumetric flasks and the volume was completed with methanol. Ten microliters of each solution was applied to TLC plate and developed as described under chromatographic conditions previously mentioned under 'Chromatographic Conditions.' The plates were visualized at 254 nm and scanned at 275 nm by densitometer. Calibration curve was plotted representing the relationship between the average peak area and concentration and the regression equation was recorded.
Calibration for HPLC Method Aliquots of standard solution (0.04 mg ml Ϫ1 ) equivalent to (0.01-0.12 mg) lamotrigine were transferred into 10-ml volumetric flasks and the volume was completed to the mark with the mobile phase. Triplicate 20 ml injections were made of each concentration. The average peak areas were calculated and plotted versus concentrations, linear relationship was obtained and the regression equation was recorded.
Application to Tablets The above producers were applied to the analysis of lamictal tablets, using sample preparation as mentioned under 'Sample Preparation.' The concentration of lamotrigine was calculated from the recorded regression equations.
Results and Discussion
Method Development. Spectrophotometric Method The UV absorption spectra of lamotrigine and its impurity 2,3-dichlorobenzoic acid display complete overlap from 200-320 nm in methanol and dilute acid with broad maximum absorption at 275 nm (Fig. 2) . The reaction of lamotrigine with p-chloranilic acid yields an immediate pink color at an ambient temperature 25Ϯ5°C with a characteristic l max 519Ϯ2 nm (Fig. 3) . This bathochromic shift is due to the formation of ion-association complex between lamotrigine and p-chloranilic acid which confirmed by IR spectra, while 2,3-dichlorobenzoic acid fails to give this reaction. So, this method could be used as stability-indicating assay. All factors affecting the formation of ion-association complex namely, reagent concentration, solvent used, temperature and reaction time were thoroughly studied. The optimum conditions were incorporated into the general procedure. Beer's law was over concentration range 10-200 mg/ml and the parameters of the regression equation are shown in Table 1 . Several organic solvents as methanol, ethanol, dichloromethane, acetonitrile and acetone were tried. Acetone was found to be the best solvent for lamotrigine and p-chloranilic acid ion-association complex formation because it has a high relative permittivity which ensure the maximum yield of ionassociation complex. The possibility of ion-association complex formation was that, both lamotrigine and p-chloranilic acid became partially positive and negative charged ions, respectively in acetone as shown in Chart 1. The composition of ion-pair association complex was established by applying Job's method of continuous variation 19) the plot reached a maximum value at a mole fraction of 0.5 which indicated the formation of 1 : 1 (drug : reagent) complex as shown in (Fig.  4) . The conditional stability constant (K f ) of the ion-association complex was calculated from the continues variation data using the following equation 20) :
Where A and A m are the observed maximum absorbance and the absorbance value when all the drug present is associated, respectively. C M is the mole concentration of drug at the maximum absorbance and n is the stoichiometry which pchloranilic acid ion associates with drug. The log K f value was found to be 5.83.
The free energy changes (DG) of the complexation 21) between the ions of drug and reagent is related to the overall stability constant, K f by the following relationship:
where R is the universal gas constant, 1.987 cal/mol; T is absolute temperature in Kelvin and DG is Gibb's free energy. The calculated association energy of the complex is Ϫ7.91 cal mol
Ϫ1
. The indication is that the complex can be formed without an external supply of energy. The molar absorptivity (mol Ϫ1 cm
) and sensitivity index (mg cm
Ϫ2
) were found to be 1.28ϫ10 3 and 1.91ϫ10
Ϫ3
, respectively. Thin Layer Chromatographic Method In this work, TLC densitometric method was used for the lamotrigine determination in presence of its main impurity, 2,3-dichlorobenzoic acid depending on the difference in Rf values. The experimental conditions for TLC method such as mobile phase composition, scan mode and wavelength of detection were optimized to provide accurate, precise and reproducible results. The chosen scan mode was zigzag mode and the wavelength of scanning was chosen to be 275 nm ( Table 1 .
HPLC Method The developed HPLC method was applied to the determination of lamotrigine in the presence of its impurity 2,3-dichlorobenzoic acid. To optimize HPLC assay parameters, the mobile phase composition and pH were studied. A satisfactory separation was obtained with a mobile phase of acetonitrile : methanol : 0.01 M potassium orthophosphate pH 6.7Ϯ0.1 (30 : 20 : 50 v/v/v) using C 18 column at ambient temperature. The analysis was carried out by isocratic elution with flow rate 1.5 ml/min and detection at 275 nm (Fig. 6) . A linear range of 1-12 mg ml Ϫ1 was obtained with mean accuracy 99.50Ϯ1.30% as show in Table 1 .
The system suitability tests of HPLC method were evaluated Table 2 .
Methods Validation. Linearity/Range Seven solutions were prepared for the linearity test. Each solution was measured (or injected) three times and linear regression analysis of lamotrigine was driven (Table 1) .
Precision The precision of the methods were assessed by determining RSD values of intra-day and inter-day analysis (nϭ9) of lamotrigine standard solutions over 3 d (Table 1) . The injection repeatability for HPLC method was determined (Table 2) .
Accuracy The accuracy of the three suggested methods was estimated based on the mean percentage accuracy of measured concentrations (nϭ6) to the actual concentration as (Table 1 ). The calculated t-test and F-test are not exceeding their theoretical values at pϭ0.05, indicating that there is no significant difference between each method and the reported one. Moreover, one-way Analysis of Variance (ANOVA) has been calculated for the proposed methods and the reported one. Source of variation as treatments (between columns) and residuals (within column), shows no significant difference among them. Specificity Synthetic mixtures of the intact drug and its impurity 2,3-dichlorobenzoic acid in different proportions 0.1-10% were analyzed as shown in Table 3 . The acceptance criteria set forth by the manufacturers for this impurity is less than reported limit of the impurity is less than 0.2%.
3)
Standard Addition Technique The proposed methods were applied for the analysis of the drug in pharmaceutical dosage form. The validity of the methods was assessed by applying the standard addition technique. The results in (Table 4 ) indicate no interference from tablets excipients such as calcium carbonate, hydroxypropyl cellulose, aluminium magnesium silicate, povidone, sodium starch glycolate, saccharin sodium and magnesium stearate. Moreover, 2,3-dichlorobenoic acid was found to be within the specified limit 0.2%.
Conclusion
The presented work describes validated spectrophotometric; TLC and HPLC methods for the assay of lamotrigine in presence of its impurity. The three suggested methods are simple, selective, accurate and can be used for the routine quality control analysis of the cited drug either in bulk or in dosage form without any interference from common excipients. The spectrophotometric method is rapid with low cost for both identification and quantification, moreover no color reaction has been reported up till now for its analysis. 
